Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NEUROCOV

Financiado

The pandemic within: tackling brain vulnerability in COVID19 at high resolution:...

The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV The COVID19 pandemic has shown our health care fragility vis a vis novel pathogens, with a global disruption on societal welfare. Despite the towering success of vaccine development, lack of preparedness on integrative clinical an... ver más

31/08/2027

BUNDESMINISTERIUM...

8M€

Presupuesto del proyecto: 8M€

Líder del proyecto

BUNDESMINISTERIUM FUER GESUNDHEIT No se ha especificado una descripción o un objeto social para esta compañía.

Ver 12 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-05-20

HORIZON-HLTH-2021-DISEASE-04-07: Personalised medicine and infectiou... ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or...

I+D

Cerrada hace 3 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

12 Participantes

BUNDESMINISTERIUM FUER GESUN...

1.84M€ | Lider

HELSINGIN YLIOPISTO

359.84K€ | Participante

AZIENDA SOCIOSANITARIA TERRI...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

TED2021-130409A-C52 CAMBIOS EN LA CONECTIVIDAD CEREBRAL FUNCIONAL Y ESTRUCTURAL... 121K€ Cerrado

TED2021-130747B-C21 VIGILANCIA DE LA IDEACION DE SUICIDIO EN ADOLESCENTES: HERRA... 150K€ Cerrado

PID2020-119677RB-I00 ASPECTOS BIO-COGNITIVOS MODULABLES Y UN CAMINO HACIA EL BIEN... 97K€ Cerrado

PSI2009-14415-C03-02 GENETIC BASIS OF THE EXECUTIVE FUNCTION IMPAIRMENT IN MCI PA... 97K€ Cerrado

PSI2017-88416-R PREDICCIONES EMOCIONALES: EFECTOS SOBRE EL COMPORTAMIENTO, B... 98K€ Cerrado

SAF2014-56197-R EXPRESION GENICA DIFERENCIAL Y CATALOGO DE CAMBIOS EN ELEMEN... Cerrado

Duración del proyecto: 63 meses Fecha Inicio: 2022-05-20
Fecha Fin: 2027-08-31

Líder del proyecto

BUNDESMINISTERIUM FUER GESUNDHEIT No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 8M€

Descripción del proyecto The COVID19 pandemic has shown our health care fragility vis a vis novel pathogens, with a global disruption on societal welfare. Despite the towering success of vaccine development, lack of preparedness on integrative clinical and molecular phenotyping has emerged with clarity and highlights the need to scale translational efforts for personalized prevention and therapy. Of particular concern are the long-term consequences of SARS-CoV-2 infection with high and rising prevalence of chronic manifestations referred to as Post-COVID. Among these the neurological and psychiatric complications stand out for frequency, lack of treatment and devastating impact of their effects at pandemic scale. Here, we tackle the cognitive and neurodegenerative complications of COVID-19, referred to as NeuroCOVID, as a ticking pandemic within the pandemic that requires an innovation leap across disciplines. We pursue a multi scalar approach that reaches from epidemiology and mechanistic interrogation of host/virus interplay at single cell resolution through predictive modelling all the way to validation of biomarkers and repurposed drugs. The aim is to anticipate and effectively manage personalized trajectories of NeuroCOVID vulnerability and their impact at population level. For this we leverage two leading national health registries and three clinical cohorts to characterize the phenotypic spectrum of NeuroCOVID, its risk factors and its socioeconomic burden at high definition. We pioneer innovative robotics to scale brain organoid modelling and combine it with single cell multiOMICs and AI analytics to dissect the principles of the individual host response and render experimentally actionable the authentic genetic backgrounds of differential SARS-CoV-2 sensitivity. Through a substantive engagement of patients’ collectives and health care stakeholders, upstream integration of innovative pipelines streamlines translation and operationalizes precision medicine for emerging medical needs.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores